Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Anika Therapeutics Inc. (ANIK) had Receiveable Turnover of 1.15 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$29.61M |
|
$-5.06M |
|
$10.62M |
|
$19.00M |
|
$35.10M |
|
$-5.49M |
|
$0.67M |
|
$-4.82M |
|
$-4.82M |
|
$-5.06M |
|
$-5.06M |
|
$-5.06M |
|
$-5.06M |
|
$-5.49M |
|
$-4.08M |
|
13.53M |
|
13.53M |
|
$-0.37 |
|
$-0.37 |
|
| Balance Sheet Financials | |
$93.56M |
|
$39.72M |
|
$85.83M |
|
$179.39M |
|
$20.97M |
|
-- |
|
$24.52M |
|
$45.49M |
|
$133.90M |
|
$124.36M |
|
$133.90M |
|
13.36M |
|
| Cash Flow Statement Financials | |
$-4.85M |
|
$-1.24M |
|
$-10.35M |
|
$57.48M |
|
$41.02M |
|
$-16.46M |
|
$6.64M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.46 |
|
-- |
|
-- |
|
-- |
|
-- |
|
64.15% |
|
-18.53% |
|
-18.53% |
|
-- |
|
-16.28% |
|
-17.07% |
|
$-6.28M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
0.46 |
|
|
Receiveable Turnover |
1.15 |
78.32 |
|
-3.78% |
|
-4.07% |
|
-2.82% |
|
-3.78% |
|
$10.02 |
|
$-0.46 |
|
$-0.36 |
|